- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14:18 | Safusidenib shows 44% response rate in IDH1-mutant glioma study | ||
| 14:18 | Tom Wyatt returns as KinderCare CEO, replacing Paul Thompson | ||
| 14:18 | Sutro Biopharma doses first patients in phase 1 trial of STRO-004 | ||
| 14:18 | United Rentals stock price target lowered to $1,000 by KeyBanc | ||
| 14:18 | Acadia Healthcare stock price target lowered to $25 at KeyBanc on higher costs | ||
| 14:18 | Synopsys stock price target lowered to $575 at KeyBanc on NVIDIA dilution | ||
| 14:18 | Cantor Fitzgerald lowers Acadia Healthcare stock price target to $17 | ||
| 14:18 | Marvell price target raised to $110 from $90 at Cantor Fitzgerald | ||
| 14:18 | JPMorgan downgrades Nankai Electric Railway stock rating to Neutral | ||
| 14:18 | GitLab stock falls 9% despite revenue beat as NRR declines | ||
| 14:18 | Bernstein sees brighter outlook for consumer stocks with global exposure | ||
| 14:18 | Cantor Fitzgerald reiterates Overweight rating on Okta stock at $115 | ||
| 14:18 | GitLab stock rating reiterated at Overweight by Cantor Fitzgerald | ||
| 13:42 | Goldman Sachs discloses trading activity in Avadel Pharmaceuticals | ||
| 13:42 | Goldman Sachs discloses trading position in Permanent TSB shares | ||
| 13:42 | Glencore aims to reach 1 million tonnes of copper production by 2028 | ||
| 13:42 | H.C. Wainwright maintains Buy rating on Engene stock as detalimogene joins FDA pilot program | ||
| 13:42 | Nuvectis Pharma stock rating reiterated at Buy by H.C. Wainwright | ||
| 13:42 | Harmony Biosciences stock maintains Buy rating at H.C. Wainwright after positive trial data | ||
| 13:42 | Leerink Partners downgrades BioMarin stock rating to Market Perform | ||
| 13:42 | H.C. Wainwright raises Tanzanian Gold stock price target to $1.40 on strong results | ||
| 13:42 | Leerink Partners upgrades Spruce Biosciences stock to Outperform | ||
| 13:42 | Leerink Partners downgrades Aurinia Pharmaceuticals stock rating on growth concerns | ||
| 13:42 | Leerink Partners upgrades Design Therapeutics stock to Outperform on pipeline progress | ||
| 13:42 | Applied Therapeutics stock rating downgraded by Leerink Partners on cash concerns |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .